Double maintains 1 strategies that include ENTA - Enanta Pharmaceuticals, Inc.
Current Value
$8.031 Year Return
Current Value
$8.031 Year Return
Finnhub
WATERTOWN - Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, announced that the U.S....
Yahoo
WATERTOWN, Mass., June 11, 2025--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for MAVYRET® (glecaprevir/pibrentasvir), an oral pangenotypic direct acting antiviral (DAA) therapy. It is now approved as the only eight-week treatment for adults and pediatric patients three yea
Yahoo
WATERTOWN, Mass., May 27, 2025--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 8:10 a.m. ET in New York, NY.
Yahoo
WATERTOWN, Mass., May 22, 2025--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that data from the Company’s Phase 2 study of zelicapavir in young children infected with respiratory syncytial virus (RSV) will be available as an E-Poster at the 43rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) 2025, being held May 26-30
Yahoo
The consensus price target hints at an 189.6% upside potential for Enanta Pharmaceuticals (ENTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
Investors in Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA ) had a good week, as its shares rose 2.4% to close at US$5.18...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CRSR | 44.24% | $1.03B | -6.27% | 0.00% |
| ALEC | 42.11% | $149.99M | -65.99% | 0.00% |
| BEAM | 39.13% | $2.00B | -15.33% | 0.00% |
| KRYS | 38.52% | $4.08B | -20.39% | 0.00% |
| EDSA | 38.01% | $14.33M | -51.66% | 0.00% |
| ATXS | 36.24% | $323.37M | -36.33% | 0.00% |
| EDIT | 35.96% | $214.31M | -45.06% | 0.00% |
| NTLA | 35.94% | $1.11B | -53.25% | 0.00% |
| MTW | 35.58% | $452.26M | +17.60% | 0.00% |
| ACAD | 35.52% | $3.55B | +36.24% | 0.00% |
| CLDX | 35.51% | $1.47B | -38.43% | 0.00% |
| ARWR | 35.49% | $2.33B | -32.59% | 0.00% |
| ATEX | 35.40% | $468.89M | -35.46% | 0.00% |
| VRDN | 35.19% | $1.24B | +24.33% | 0.00% |
| PDSB | 35.19% | $58.05M | -57.81% | 0.00% |
| COGT | 35.15% | $843.67M | -11.36% | 0.00% |
| KOD | 35.07% | $202.08M | +74.09% | 0.00% |
| ANAB | 34.96% | $701.61M | -4.10% | 0.00% |
| ABCL | 34.92% | $1.12B | +38.38% | 0.00% |
| LECO | 34.81% | $11.94B | +15.18% | 1.38% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| WST | -23.63% | $15.89B | -31.06% | 0.37% |
| TTD | -12.30% | $36.16B | -26.03% | 0.00% |
| CBOE | -11.83% | $24.23B | +35.36% | 1.09% |
| K | -11.28% | $27.76B | +41.17% | 2.85% |
| DOGZ | -9.39% | $121.58M | -48.38% | 0.00% |
| TNET | -7.98% | $3.58B | -25.50% | 1.41% |
| SMWB | -7.63% | $704.05M | +14.71% | 0.00% |
| LRN | -7.53% | $5.99B | +100.06% | 0.00% |
| VSTA | -7.20% | $344.07M | +39.29% | 0.00% |
| UL | -7.07% | $150.63B | +11.64% | 3.17% |
| KR | -6.82% | $46.43B | +38.38% | 1.85% |
| QNTM | -6.40% | $51.94M | +107.44% | 0.00% |
| LQDT | -6.35% | $753.04M | +21.88% | 0.00% |
| LITB | -6.34% | $21.24M | -78.57% | 0.00% |
| PEGA | -5.81% | $9.01B | +80.22% | 0.23% |
| CNK | -5.61% | $3.47B | +41.29% | 0.53% |
| NOC | -4.73% | $71.81B | +14.14% | 1.69% |
| LFVN | -4.26% | $168.68M | +123.71% | 1.22% |
| MSIF | -4.23% | $769.47M | +36.17% | 7.61% |
| BTI | -3.65% | $103.67B | +50.78% | 6.33% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 43.12% | $4.82B | 0.35% |
| IBB | 42.72% | $5.26B | 0.45% |
| GNOM | 42.44% | $44.57M | 0.5% |
| XPH | 40.63% | $147.96M | 0.35% |
| PTH | 39.67% | $100.85M | 0.6% |
| ARKG | 38.85% | $1.02B | 0.75% |
| BBH | 38.40% | $330.62M | 0.35% |
| PBE | 38.01% | $223.19M | 0.58% |
| IWC | 37.61% | $818.14M | 0.6% |
| FBT | 36.87% | $1.01B | 0.54% |
| VHT | 36.28% | $15.35B | 0.09% |
| PINK | 35.84% | $130.57M | 0.5% |
| KJUL | 35.61% | $119.50M | 0.79% |
| FHLC | 35.42% | $2.44B | 0.084% |
| IHE | 34.40% | $550.45M | 0.39% |
| IYM | 34.24% | $545.92M | 0.39% |
| IYH | 34.19% | $2.73B | 0.39% |
| VAW | 34.03% | $2.67B | 0.09% |
| XLV | 33.98% | $34.28B | 0.09% |
| XLB | 33.93% | $5.35B | 0.09% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -26.62% | $164.54M | 0.85% |
| TAIL | -24.88% | $99.63M | 0.59% |
| BTAL | -20.17% | $296.22M | 1.43% |
| XONE | -18.16% | $625.28M | 0.03% |
| XHLF | -11.40% | $1.73B | 0.03% |
| IVOL | -10.50% | $347.03M | 1.02% |
| STOT | -10.08% | $254.07M | 0.45% |
| FXY | -9.84% | $816.38M | 0.4% |
| IBTH | -9.80% | $1.62B | 0.07% |
| VGSH | -9.59% | $22.80B | 0.03% |
| TFLO | -9.41% | $6.82B | 0.15% |
| UTWO | -9.29% | $379.52M | 0.15% |
| SPTS | -9.16% | $5.80B | 0.03% |
| ULST | -8.95% | $654.75M | 0.2% |
| SCHO | -8.43% | $11.03B | 0.03% |
| SHYM | -8.04% | $357.13M | 0.35% |
| BILS | -7.96% | $3.81B | 0.1356% |
| TBLL | -7.46% | $2.13B | 0.08% |
| IBTI | -7.25% | $1.06B | 0.07% |
| SHY | -7.25% | $23.83B | 0.15% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RYAN | 0.03% | $8.33B | +14.50% | 0.70% |
| SLF | -0.08% | $36.54B | +30.65% | 3.74% |
| FATBB | -0.11% | $49.01M | -5.66% | 10.18% |
| HRTG | -0.15% | $702.31M | +250.23% | 0.00% |
| CHH | -0.17% | $6.06B | +10.94% | 0.88% |
| KTOS | 0.18% | $7.20B | +111.33% | 0.00% |
| IMNN | -0.21% | $16.26M | -34.16% | 0.00% |
| GFL | -0.22% | $17.74B | +23.55% | 0.12% |
| DAO | 0.25% | $262.76M | +119.32% | 0.00% |
| WCN | 0.30% | $46.02B | +0.33% | 0.69% |
| UGP | 0.35% | $3.55B | -17.50% | 3.68% |
| FWONK | 0.38% | $25.57B | +39.93% | 0.00% |
| CRESY | -0.45% | $671.80M | +35.90% | 5.49% |
| RILY | 0.49% | $98.51M | -80.97% | 0.00% |
| AXON | -0.52% | $60.30B | +161.18% | 0.00% |
| BAH | -0.60% | $13.43B | -29.93% | 1.93% |
| XGN | 0.61% | $152.37M | +285.08% | 0.00% |
| UVE | 0.61% | $730.36M | +42.93% | 2.45% |
| PSN | 0.63% | $7.89B | -8.31% | 0.00% |
| FDP | 0.63% | $1.59B | +52.62% | 3.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ISTB | -0.01% | $4.44B | 0.06% |
| BOND | 0.05% | $5.67B | 0.7% |
| EUSB | 0.09% | $735.36M | 0.12% |
| TDTT | 0.15% | $2.64B | 0.18% |
| XBIL | 0.16% | $783.90M | 0.15% |
| VCRB | -0.17% | $3.13B | 0.1% |
| SUB | 0.17% | $9.91B | 0.07% |
| STPZ | 0.20% | $450.47M | 0.2% |
| EAGG | 0.22% | $3.99B | 0.1% |
| BND | -0.22% | $131.38B | 0.03% |
| KMLM | 0.23% | $188.90M | 0.9% |
| YEAR | -0.26% | $1.47B | 0.25% |
| FBND | 0.27% | $19.27B | 0.36% |
| NYF | 0.29% | $892.18M | 0.25% |
| CMF | 0.31% | $3.59B | 0.08% |
| FLMI | 0.32% | $725.99M | 0.3% |
| UCON | -0.36% | $2.96B | 0.86% |
| NEAR | -0.37% | $3.34B | 0.25% |
| BBAG | 0.37% | $1.29B | 0.03% |
| IBMR | 0.38% | $255.59M | 0.18% |
